Division of Physical Sciences and Engineering, KAUST Catalysis Center, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia and Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Dalton Trans. 2017 Sep 12;46(35):11925-11941. doi: 10.1039/c7dt02194a.
The relationship between cis-trans isomerism and anticancer activity has been mainly addressed for square-planar metal complexes, in particular, for platinum(ii), e.g., cis- and trans-[PtCl(NH)], and a number of related compounds, of which, however, only cis-counterparts are in clinical use today. For octahedral metal complexes, this effect of geometrical isomerism on anticancer activity has not been investigated systematically, mainly because the relevant isomers are still unavailable. An example of such an octahedral complex is trans-[RuCl(Hind)], which is in clinical trials now as its indazolium (KP1019) or sodium salt (NKP1339), but the corresponding cis-isomers remain inaccessible. We report the synthesis of Na[cis-OsCl(κN2-1H-ind)]·(Na[1]) suggesting a route to the cis-isomer of NKP1339. The procedure involves heating (Hind)[OsCl(κN1-2H-ind)] in a high boiling point organic solvent resulting in an Anderson rearrangement with the formation of cis-[OsCl(κN2-1H-ind)] ([1]) in high yield. The transformation is accompanied by an indazole coordination mode switch from κN1 to κN2 and stabilization of the 1H-indazole tautomer. Fully reversible spectroelectrochemical reduction of [1] in acetonitrile at 0.46 V vs. NHE is accompanied by a change in electronic absorption bands indicating the formation of cis-[OsCl(κN2-1H-ind)] ([1]). Chemical reduction of [1] in methanol with NaBH followed by addition of nBuNCl afforded the osmium(iii) complex nBuN[cis-OsCl(κN2-1H-ind)] (nBuN[1]). A metathesis reaction of nBuN[1] with an ion exchange resin led to the isolation of the water-soluble salt Na[1]. The X-ray diffraction crystal structure of [1]·MeCO was determined and compared with that of trans-[OsCl(κN2-1H-ind)]·2MeSO (2·2MeSO), also prepared in this work. EPR spectroscopy was performed on the Os complexes and the results were analyzed by ligand-field and quantum chemical theories. We furthermore assayed effects of [1] and Na[1] on cell viability and proliferation in comparison with trans-[OsCl(κN1-2H-ind)] [3] and cisplatin and found a strong reduction of cell viability at concentrations between 30 and 300 μM in different cancer cell lines (HT29, H446, 4T1 and HEK293). HT-29 cells are less sensitive to cisplatin than 4T1 cells, but more sensitive to [1] and Na[1], as shown by decreased proliferation and viability as well as an increased late apoptotic/necrotic cell population.
顺反异构与抗癌活性之间的关系主要针对平面正方形金属配合物进行了研究,特别是铂(ii)配合物,例如顺式和反式-[PtCl(NH3)],以及许多相关的化合物,但目前临床上仅使用顺式对应物。对于八面体金属配合物,这种几何异构体对抗癌活性的影响尚未得到系统研究,主要是因为相关的异构体仍然不可用。八面体配合物的一个例子是反式-[RuCl(Hind)],目前正在临床试验中作为其吲唑(KP1019)或钠盐(NKP1339),但相应的顺式异构体仍然无法获得。我们报告了 Na[cis-OsCl(κN2-1H-ind)]·(Na[1])的合成,这表明 NKP1339 的顺式异构体的合成途径。该过程涉及在高沸点有机溶剂中加热(Hind)[OsCl(κN1-2H-ind)],导致安德森重排,生成顺式-OsCl(κN2-1H-ind),产率高。该转化伴随着吲唑配位模式从 κN1 到 κN2 的切换,并稳定 1H-吲唑互变异构体。[1]在 0.46 V 相对于 NHE 的乙腈中的完全可逆的光电化学还原伴随着电子吸收带的变化,表明形成顺式-OsCl(κN2-1H-ind)。在甲醇中用 NaBH 对[1]进行化学还原,然后加入 nBuNCl,得到三价锇配合物 nBuN[cis-OsCl(κN2-1H-ind)](nBuN[1])。nBuN[1]与离子交换树脂的复分解反应导致水溶性盐 Na[1]的分离。确定了[1]·MeCO 的 X 射线衍射晶体结构,并与本工作中也制备的反式-[OsCl(κN2-1H-ind)]·2MeSO(2·2MeSO)进行了比较。对 Os 配合物进行了 EPR 光谱研究,并通过配体场和量子化学理论进行了分析。我们还测定了[1]和 Na[1]对细胞活力和增殖的影响,并与反式-[OsCl(κN1-2H-ind)][3]和顺铂进行了比较,结果表明,在不同的癌细胞系(HT29、H446、4T1 和 HEK293)中,浓度在 30 至 300 μM 之间时,细胞活力明显降低。HT-29 细胞对顺铂的敏感性低于 4T1 细胞,但对[1]和 Na[1]更敏感,表现为增殖和活力降低,晚期凋亡/坏死细胞群体增加。